Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: A Bayesian network meta-regression analysis.
Frontiers in oncology（2023）
摘要
https://www.crd.york.ac.uk/prospero/, identifier CRD4202236775.
更多查看译文
关键词
efficacy,immune checkpoint inhibitors,metastatic renal cell carcinoma,network meta-regression analysis,tyrosine kinase inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要